GCVI Summit 2018
Skip Content

People

27 September 2017

USF faculty excels in awards

The university’s Excellence in Innovation awards have emphasised commercialised intellectual property based on research in neuroscience, biosensors and computer engineering.

Author: Callum Cyrus, reporter

University of South Florida (USF) commended three faculty members with Excellence in Innovation awards on Monday for patented innovations designed to help fight Alzheimer’s disease, pregnancy complications and cybercrime.

The accolade recognises achievements in commercialisation and translational research.

Paul Sanberg, senior vice-president for research, innovation and knowledge expertise at USF, said: “These awards recognise the extraordinary efforts of three individuals who are not only nationally-recognised leaders in their disciplines, but who go the extra mile to move cutting edge technologies to market where they can benefit society.”

The winners were:

  • Chuanhai Cao, now assistant professor at local healthcare agency Florida Covering Kids & Families, whose research in pharmacology, neuroscience and molecular biology has resulted in a licensed intellectual property for an electromagnetic headset for Alzheimer’s patients.
  • Anna Pyayt, an assistant professor at USF’s Department of Chemical and Biomedical Engineering, whose biosensor technology was spun out into Hemolix, a developer of mobile phone accessories and apps designed to warn of pregnancy complications.
  • Jay Ligatti, associate professor at USF’s Department of Computer Science and Engineering, whose computer security approach, Control Flow Enforcement (CFE), has been licensed by chipset maker Intel to address vulnerabilities associated with passwords and fingerprint sensors.

In May 2017, USF ranked 19th in a commercialisation and tech transfer index of US-based universities published by economic thinktank Milken Institute.

Copyright Mawsonia Limited 2010. Please don´t cut articles from www.globaluniversityventuring.com or the PDF and redistribute by email or post to the web without written permission.

  • Linkedin
  • Mail
  • Rssfeed